Apr 01, 2019
In previous lab note we mentioned that we have managed to produce the antigen ahead of schedule, first of April (today)). Now, to be able to achieve the next mile stone we need to reach the funding goal. An anonymous donor is wiling to give a $1000 pledge if we get to at least $7000 by the deadline, so the oroject will get funded. Let us hope that this will happen by April 13 th....
Adam like this.
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
Australian bats are at risk from the deadly fungal disease White Nose Syndrome (WNS), which is expected...
The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
1 comment